INTS Intensity Therapeutics, Inc.

Fundamentals / CIK 0001567264 / USD

Intensity Therapeutics, Inc. reported $10.29M in total assets and a net loss of $12.04M through December 31, 2025 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open INTS in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

4 fiscal years (2022 to 2025), reported in USD.

$0$0$0-$15.21MFY 2022 Net Income: -$7.58M2022FY 2023 Net Income: -$10.54M2023FY 2024 Net Income: -$16.27M2024FY 2025 Net Income: -$11.61M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31
Research & Development $6.79M $10.50M $4.79M $5.13M
Total Operating Expenses $11.97M $16.59M $8.32M $7.55M
Operating Income -$11.97M -$16.59M -$8.32M -$7.55M
Interest Income $180K $314K $324K $2.0K
Interest Expense -- $0 $305K $82K
Income Tax Expense $0 $0 $0 $0
Net Income -$11.61M -$16.27M -$10.54M -$7.58M
Basic EPS -$8.56 -$29.24 -$34.50 -$55.50
Diluted EPS -$8.56 -$29.24 -$34.50 -$55.50
Basic Shares Outstanding 1.4M 556.3K 344.7K 136.4K
Diluted Shares Outstanding 1.4M 556.3K 344.7K 136.4K

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Research & Development $2.43M $1.83M $1.20M $1.50M $1.55M $1.54M $2.19M $1.97M
Total Operating Expenses $3.62M $3.08M $2.53M $3.14M $2.73M $2.71M $3.39M $3.20M
Operating Income -$3.62M -$3.08M -$2.53M -$3.14M -$2.73M -$2.71M -$3.39M -$3.20M
Interest Income $82K $77K $94K $88K $59K $17K $15K $28K
Net Income -$3.54M -$3.01M -$2.43M -$3.05M -$2.67M -$2.54M -$3.35M -$3.18M
Basic EPS -$1.09 -$1.11 -$0.96 -- -$1.55 -$3.36 -$5.51 --
Diluted EPS -$1.09 -$1.11 -$0.96 -- -$1.55 -$3.36 -$5.51 --
Basic Shares Outstanding 3.3M 2.7M 2.5M -- 1.7M 754.7K 606.9K --
Diluted Shares Outstanding 3.3M 2.7M 2.5M -- 1.7M 754.7K 606.9K --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $11.92M $2.59M $8.56M $1.31M
Cash & Short-Term Investments $11.90M $2.60M $14.80M $1.31M
Other Current Assets -- -- $6.0K $76K
Total Current Assets $12.71M $3.36M $15.46M $1.45M
Other Non-Current Assets $1.30M $1.30M $1.68M $167K
Total Non-Current Assets $1.39M $1.42M $1.83M $306K
Total Assets $14.10M $4.78M $17.30M $1.76M
Accounts Payable $583K $1.22M $3.05M $603K
Total Current Liabilities $2.15M $1.75M $3.96M $6.82M
Other Non-Current Liabilities -- $0 $36K $36K
Total Non-Current Liabilities $79K $110K $174K $36K
Total Liabilities $2.23M $1.86M $4.13M $6.86M
Total Debt (incl. Leases) $110K $138K $158K $143K
Common Stock $0 $0 $1.0K $0
Retained Earnings -$78.39M -$66.78M -$50.52M -$38.65M
Total Stockholders' Equity $11.88M $2.92M $13.16M -$15.10M
Total Equity $11.88M $2.92M $13.16M -$15.10M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $8.49M $9.53M $10.24M $11.92M $7.07M $2.22M $929K $2.59M
Cash & Short-Term Investments $8.50M $9.50M $10.20M $11.90M $7.10M $2.20M $900K $2.60M
Accounts Receivable, Net $41K -- -- -- -- -- -- --
Total Current Assets $9.50M $11.23M $10.91M $12.71M $8.19M $3.04M $1.65M $3.36M
Other Non-Current Assets $710K $210K $1.30M $1.30M $1.30M $1.30M $1.30M $1.30M
Total Non-Current Assets $785K $292K $1.39M $1.39M $1.40M $1.41M $1.41M $1.42M
Total Assets $10.29M $11.52M $12.29M $14.10M $9.59M $4.44M $3.06M $4.78M
Accounts Payable $1.65M $1.01M $636K $583K $1.68M $1.19M $1.59M $1.22M
Total Current Liabilities $2.58M $2.25M $2.24M $2.15M $2.28M $2.16M $2.63M $1.75M
Other Non-Current Liabilities -- -- -- -- -- -- -- $0
Total Non-Current Liabilities $53K $62K $70K $79K $87K $95K $102K $110K
Total Liabilities $2.63M $2.31M $2.31M $2.23M $2.36M $2.26M $2.73M $1.86M
Total Debt (incl. Leases) $87K $95K $102K $110K $118K $125K $131K $138K
Common Stock $0 $0 $0 $0 $5.0K $3.0K $2.0K $0
Retained Earnings -$87.37M -$83.83M -$80.82M -$78.39M -$75.34M -$72.67M -$70.13M -$66.78M
Total Stockholders' Equity $7.65M $9.21M $9.98M $11.88M $7.22M $2.18M $334K $2.92M
Total Equity $7.65M $9.21M $9.98M $11.88M $7.22M $2.18M $334K $2.92M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$11.61M -$16.27M -$10.54M -$7.58M
Stock-Based Compensation $2.00M $3.07M $1.40M $1.17M
Operating Cash Flow -$9.23M -$15.22M -$7.21M -$5.48M
Purchases of Investments $0 -$3.06M -$15.05M $0
Investing Cash Flow $0 $6.35M -$6.02M $0
Financing Cash Flow $18.56M $2.90M $20.47M $2.25M
Net Change in Cash $9.33M -$5.97M $7.24M -$3.23M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$3.54M -$3.01M -$2.43M -$3.05M -$2.67M -$2.54M -$3.35M -$3.18M
Stock-Based Compensation $517K $387K $387K $450K $471K $644K $435K $844K
Operating Cash Flow -$2.50M -$2.34M -$1.83M -$2.40M -$2.39M -$2.46M -$1.99M -$2.67M
Investing Cash Flow -- -- -- $0 $0 $0 $0 $0
Common Stock Issued -- -- -- -- -- -- $345K --
Financing Cash Flow $1.47M $1.62M $150K $7.25M $7.24M $3.74M $328K $2.48M
Net Change in Cash -$1.03M -$716K -$1.68M $4.85M $4.85M $1.29M -$1.66M -$192K

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31
Return on Equity (ROE) -97.7% -557.5% -80.1% --
Return on Assets (ROA) -82.3% -340.1% -60.9% -431.5%
Current Ratio 5.92x 1.92x 3.91x 0.21x
Quick Ratio 5.55x 1.48x 3.74x 0.19x
Debt to Equity 0.01x 0.05x 0.01x --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Return on Equity (ROE) -157.3% -121.2% -107.2% -97.7% -162.5% -575.9% -4494.6% -557.5%
Return on Assets (ROA) -117.0% -96.9% -87.0% -82.3% -122.4% -283.1% -489.8% -340.1%
Current Ratio 3.68x 5.00x 4.86x 5.92x 3.60x 1.40x 0.63x 1.92x
Quick Ratio 3.31x 4.23x 4.55x 5.55x 3.12x 1.02x 0.34x 1.48x
Debt to Equity 0.01x 0.01x 0.01x 0.01x 0.02x 0.06x 0.39x 0.05x
Source: SEC EDGAR CompanyFacts (CIK 0001567264) · from June 30, 2022 Data through September 30, 2026 · synced Nov 21, 2026, 05:07 UTC · Open in terminal